本页面由Tiger Trade Technology Pte. Ltd.提供服务

Oncternal Therapeutics, Inc.

0.5266
0.0000
成交量:- -
成交额:- -
市值:155.85万
市盈率:-0.05
高:0.5266
开:0.5266
低:0.5266
收:0.5266
52周最高:0.5266
52周最低:0.5266
股本:295.96万
流通股本:270.64万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-11.6916
每股收益(LYR):-13.4282
净资产收益率:-149.86%
总资产收益率:-74.11%
市净率:0.17
市盈率(LYR):-0.04

数据加载中...

2021/03/11

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/11

重要事件披露

8-K - Current report
2021/03/01

重要事件披露

8-K - Current report
2021/02/17

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/28

重要事件披露

8-K - Current report
2020/12/18

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/18

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/11

重要事件披露

8-K - Current report
2020/12/10

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/12/10

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/12/07

重要事件披露

8-K - Current report
2020/11/19

重要事件披露

8-K - Current report
2020/11/18

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/11/17

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/11/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/04

重要事件披露

8-K - Current report
2020/08/31

重要事件披露

8-K - Current report
2020/08/28

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses